|Day Low/High||22.35 / 22.77|
|52 Wk Low/High||20.48 / 28.60|
These five technical setups are showing solid upside potential right now.
The health care sector is booming, but many stocks are overvalued. We pinpoint the best buys now in the medical device niche.
These medical device makers could be acquisition targets (and one buyer) following Zimmer Biomet's takeout of LDR Holding. Their charts are also buys, says technical chartist Bruce Kamich.
The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Globus Medical Inc , where a total volume of 3,046 contracts has been traded thus far today, a contract volume which is representative of approximately 304,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 54.1% of GMED's average daily trading volume over the past month, of 563,450 shares.
The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.
Globus Medical (GMED) coverage was started with an ‘equal weight’ rating and $26 price target at Barclays.
Here are Monday's top research calls, including upgrades for J.C. Penney and Nokia, a downgrade for Kohl's and new coverage of Microsoft.
Trade-Ideas LLC identified Globus Medical (GMED) as a weak on high relative volume candidate
Investors in Globus Medical Inc saw new options become available this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GMED options chain for the new May 20th contracts and identified one put and one call contract of particular interest.
Investors in Globus Medical Inc saw new options become available this week, for the September 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Here are Friday's top research calls, including a downgrade for Aetna, and upgrades for Cigna, Cirrus Logic and Foot Locker.
Marcus & Boxerman announces that a securities class action lawsuit has been filed against Globus Medical, Inc.